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SUMMARY
The prevalence of colonization with the anaerobic intestinal spirochaetes Brachyspira aalborgi
and Brachyspira pilosicoli was investigated in humans (n=316) and dogs (n=101) living on three
tea estates in Assam, India. Colonization was detected using PCR on DNA from faeces. Nineteen
(6%) human faecal samples contained B. aalborgi DNA, 80 (25.3%) contained B. pilosicoli
DNA, and 10 (3.2%) contained DNA from both species. One canine sample contained DNA
from B. pilosicoli. Signiﬁcant factors for B. aalborgi colonization in logistic regression were:
infection of family members with B. aalborgi (P<0.001), being a resident of Balipara (P=0.03),
and use of water treatment (P=0.03). For B. pilosicoli, signiﬁcant factors were: other family
members being positive for B. pilosicoli (P<0.001), water obtained from a well (P=0.006), water
treatment (P=0.03), and not having visited a doctor in the previous 12 months (P=0.03).
INTRODUCTION
Two species of anaerobic intestinal spirochaetes have
been reported to colonize the lower intestinal tract
of humans: Brachyspira aalborgi [1] and Brachyspira
pilosicoli [2, 3]. Both species have been associated with
a condition called intestinal spirochaetosis (IS), in
which a fringe can be seen in histological sections of
the colorectal epithelium, caused by end-on attach-
ment of large numbers of spirochaetes. IS has been
linked to a number of symptoms, including chronic
diarrhoea, rectal bleeding, pseudo-appendicitis, and
lower abdominal discomfort [4–7].
Of these two species, B. pilosicoli has been isolated
and identiﬁed in a number of studies. It has been
shown to colonize approximately 30% of individuals
in developing countries including Oman [8] and Papua
New Guinea [9], and, in developed countries, occurs
at a similarly high prevalence in Aboriginal people
in Australia [10], male homosexuals [3] and patients
infected with human immunodeﬁciency virus (HIV)
[11]. By comparison, it is uncommon in the faeces of
the general population in developed countries [10, 12,
13]. It is also regularly found in the large intestines of
a variety of animal species including pigs [2], chickens
[14], water birds [15], and dogs [16]. This spirochaete
species also can be invasive, and has been isolated
from the bloodstream of immunocompromised indi-
viduals in Europe and the United States [17–20].
No similar epidemiological studies have been con-
ducted on B. aalborgi, largely because the organism
is extremely fastidious, taking up to 3 weeks to grow
under anaerobic incubation on specialized media. To
date, B. aalborgi has only been reported to have been
isolated from humans in ﬁve studies; in three it was
grown from colorectal biopsies [1, 21, 22], and in two
it was grown from faeces [23, 24]. In recent studies,
DNA has been extracted from colorectal biopsies
taken from IS patients in Australia, Scandinavia and
the United States, and ampliﬁed by polymerase chain * Author for correspondence.
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probes. Somewhat unexpectedly, these studies showed
that B. aalborgi is much more commonly involved
in IS in these developed countries than is B. pilosicoli
[21, 25–28]. Similar studies have not been conducted
on patients in developing countries, where B. pilosicoli
is known to be common, due to diﬃculties in access-
ing suitable samples. Although one histological study
in Southern India demonstrated that IS occurs com-
monly in apparently healthy villagers [29], the spiro-
chaetes present in these samples were not identiﬁed.
Recently, the PCR techniques used on DNA ex-
tracted from biopsies have been adapted for the de-
tection of B. aalborgi and B. pilosicoli in human faeces
[30]. Faecal samples are much easier to obtain than
are colorectal biopsies, and hence this technology
will facilitate epidemiological studies on these spiro-
chaetes.
The current study used PCR to test faeces col-
lected from individuals in a remote rural community
in northeast India, to establish the comparative preva-
lences of the two spirochaetes. It is the ﬁrst study to
examine the distribution of B. aalborgi in a developing
country, and the ﬁrst to examine B. pilosicoli in India.
The samples examined were collected as part of a
separate study investigating gastrointestinal parasites
in dogs and human beings [31]. Data from a ques-
tionnaire administered with the original survey also
were analysed in relation to colonization with intes-
tinal spirochaetes.
METHODS
Collection and processing of faecal samples
The faecal samples examined were from 316 randomly
selected people from the three tea-growing estates
of Phulbari, Addabarie and Balipara, located in the
Indian state of Assam. The estates were situated
within a 10 km radius, and had reported populations
of 6531, 4839 and 2004 individuals respectively.
Faecal samples from 101 dogs from the estates also
were collected. All the samples were obtained as part
of a separate study into gastrointestinal parasites,
and fuller details of the sample origin and sampling
methodology have been published elsewhere [31]. To
satisfy Australian quarantine requirements, the faeces
were stored in 2.5% potassium dichromate solution
for transportation to Australia, and were refrigerated
at 4 xC upon arrival at Murdoch University. The
dichromate solution was washed oﬀ prior to DNA
extraction. Samples of faeces (0.2 g) were pelleted at
14000 r.p.m. for 1 min, the supernatant discarded
and the pellet resuspended in 1 ml sterile phosphate
buﬀered saline (PBS) and centrifuged again. The
process was repeated, and the ﬁnal pellet was used for
DNA extraction.
Questionnaire
At the time of sample collection, participants were
asked to ﬁll in a questionnaire to gather the following
information relating to potential risk factors for infec-
tion: gender, age, religion, estate, level of education,
occupation, type of toilet used, drinking water source,
type of treatment of water, visits to the doctor in the
previous 12 months, animal ownership, ownership of
dogs, cats, cattle, buﬀalo, sheep, goats, pigs, birds,
horses, donkeys and rabbits. Relevant questions relat-
ing to symptoms at time of collection were: whether
theindividualsweresuﬀeringfromdiarrhoea,abdomi-
nal pain or weight loss. Diarrhoea was explained as
increased frequency and water content of the stools,
above that considered normal.
Control strains
Control strains of B. aalborgi and B. pilosicoli,
obtained from the culture collection at the Reference
Centre for Intestinal Spirochaetes at Murdoch Uni-
versity, were used in the PCRs as positive and
negative controls. B. aalborgi type strain 513T and
B. pilosicoli human strain WesB were propagated
anaerobically on non-selective Trypticase soy agar
containing 5% (v/v) deﬁbrinated sheep blood in
an atmosphere of 94% H2 and 6% CO2 at 37 xC for
15 days. Viable cells were scraped from the agar and
suspended in TE buﬀer (10 mM Tris–HCl, 1 mM
EDTA; pH 8.0) to a concentration of 10
11 cells/ml.
Seeding of faeces
The sensitivities of the PCRs for detection of the two
species were established by seeding two faecal samples
selected from the series with known concentrations
of cells of the respective species. The faecal samples
used were negative for spirochaetes by phase contrast
microscopy, and by selective culture and PCR for
both spirochaete species. A range of 500 ml serial di-
lutions of the 10
11 stocks, from 10
11 to 10
1, were added
to 0.2 g of faeces and vortexed until homogenous.
Negative controls consisted of 0.2 g faeces with 500 ml
sterile PBS.
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DNA was extracted from the seeded faeces, and the
faeces collected in the survey, by use of the QIAamp
DNA stool mini kit (Qiagen GmbH, Germany), used
according to the manufacturer’s instructions. In each
case, 0.2 g of faeces was processed through the three
main steps in the protocol: lysis of bacterial cells in the
stool sample; adsorption and removal of impurities,
inhibitors and debris; puriﬁcation of extracted DNA
throughQIAampspincolumns.TheDNAyieldvaried
between 5 and 100 mg, depending on the sample being
processed.
PCRs
The PCRs used were based on those described for
detection of the spirochaete species in human colo-
rectal biopsies and faeces [25, 28, 30]. For B. aalborgi,
a 471-bp section of the 16S rRNA gene equivalent to
the base-pair positions 172–675 of the 16S rRNA gene
ofEscherichiacoliwastargetedforPCRampliﬁcation.
For B. pilosicoli, a 439-bp section of the 16S rRNA
gene equivalent to the base-pair positions 204–676
of the 16S rRNA gene of E. coli was ampliﬁed.
The ampliﬁcation mixtures contained 25 ml reac-
tion mix of 1r PCR buﬀer, 0.55 U of Tth plus DNA
polymerase, 1.5m M of MgCl2, 5 nmol of each deoxy-
nucleoside triphosphate (Amersham Pharmacia Bio-
tech AB, Uppsala, Sweden) and 12.5 pmol of each
primer.Thermocyclingconsistedof4 min30 sdenatu-
ration at 94 xC followed by 33 cycles of denaturation
at 94 xC for 30 s, annealing for 30 s at 46 xC for
B. aalborgi or 51 xC for B. pilosicoli, primer extension
at 72 xC for 30 s, and a ﬁnal extension at 72 xC for
5 min. The PCR products were subjected to electro-
phoresis in 1.5% agarose gels in 1r TAE buﬀer
(40 mM Tris–acetate, 1 mM EDTA) for 25 min at
110 V, stained by immersion for 10 min in ethidium
bromide at a concentration of 0.001 mg/ml in distilled
water and viewed over UV light.
Sequencing of PCR products
Ampliﬁed products from 16 human faecal samples
(eight B. aalborgi positive and eight B. pilosicoli posi-
tive), and the canine faecal sample that was positive
for B. pilosicoli were puriﬁed using a MoBio Ultra
Clean PCR clean up DNA puriﬁcation kit (MoBio
Laboratories, Carlsbad, CA, USA), according to the
manufacturer’s instructions. DNA in the eluent was
then sequenced using a ABI PRISM dye terminator
cycle sequencing ready reaction kit (ABI Applied
Biosystems, Foster City, CA, USA), according to
the manufacturer’s instructions. The sequence data
obtained were aligned and compared with 16S rDNA
sequences of the B. aalborgi and B. pilosicoli type
strains using SeqEd version 1.0.3 (ABI Applied Bio-
systems).
Statistical analysis
The prevalence and 95% conﬁdence interval (CI)
were calculated for each species of intestinal spiro-
chaete. Associations between the presence of the
spirochaete species and host and environmental fac-
tors were initially made using univariate x
2 tests for
independence. Continuous data (age) were analysed
using one-way analysis of variance. Logistic re-
gression models were developed for both spirochaete
species in relation to potential risk factors for colon-
ization, and for potential clinical signs. Only variables
signiﬁcant at P<0.25 in the univariate analysis
were considered eligible for inclusion in the logistic
regression models [32]. Backward elimination was
used to determine which factors could be dropped
from the model. The likelihood ratio x
2 statistic was
calculated to determine the signiﬁcance at each step
of the model building. The level of signiﬁcance for a
factor to remain in a ﬁnal model was set at 10%.
Statistical comparisons were performed using Stat-
istix for Windows (Analytical Software, Tallahassee,
FL, USA), Excel 97 (Microsoft Corporation, USA),
and Egret for Windows (version 2.0.3, Cytel Soft-
ware, Cambridge, MA, USA).
RESULTS
Sensitivity of PCRs on seeded faeces
The lower level of detection for the B. aalborgi-
speciﬁcPCRwasbetween2.5r10
4and2.5r10
5 cells/g
of faeces, equivalent to 2.5r10
2 to 2.4r10
3 cells
per PCR reaction. For B. pilosicoli the lower limit
of detection was between 2.5r10
5 and 2.5r10
6 cells/g
of faeces or 2.5r10
3 to 2.5r10
4 cells per PCR
reaction.
Prevalence of disease symptoms
At the time of sampling, 18 people (5.7%) reported
having diarrhoea, 29 (9.2%) reported abdominal
pain, and 68 (21.5%) recorded that they had suﬀered
weight loss.
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Nineteen (6%; 95% CI 3.4–8.6) of 316 people tested
gave a positive ampliﬁcation with the B. aalborgi
PCR. These included 10/145 (6.9%) individuals from
Phulbari, 4/122 (3.3%) from Addabarie and 5/49
(10.2%) from Balipara. None of the 101 dogs tested
were PCR positive for B. aalborgi. Alignment of the
443-bp sequence of products from eight individuals
from the three sites conﬁrmed the speciﬁcity of the
PCR reaction – with the products all having >98.6%
sequence homology with the B. aalborgi-type strain,
and <94.2% homology with the B. pilosicoli-type
strain.
Risk factors for B. aalborgi
Ten individuals (3.2%) were colonized with both B.
aalborgi and B. pilosicoli, and there was a signiﬁcant
association between this dual colonization (x
2=7.98;
P=0.005). There was no signiﬁcant association be-
tween colonization and age. Twenty variables were
included in the initial univariate x
2 analysis, and
potential risk factors for colonization with B. aalborgi
(i.e. those with P<0.25) are shown in Table 1. These
included other family members being colonized with
B. aalborgi, estate, religion, visits to a doctor in the
preceding 12 months, type of worker, water being
treated, owning any type of animal, owning a dog,
owning a cat, owning a cow, owning a goat, and
owning a pig. The factors remaining signiﬁcant after
logistic regression were: other family members being
colonized with B. aalborgi (P<0.001), being a resident
of Balipara (P=0.03), and treating drinking water
(P=0.03) (Table 2).
Disease association with B. aalborgi
None of the three symptoms analysed had a signiﬁ-
cant association with B. aalborgi colonization.
Prevalence of B. pilosicoli
Eighty (25.3%; 95% CI 20.5–30.1) of the 316 people
tested, and one of the dogs (1%) were PCR positive
for B. pilosicoli. Positive individuals came from
Phulbari,(53/145;36.6%)Addabarie(23/122;18.9%)
and Balipara (4/49; 8.2%), whilst the positive dog
was from Balipara. Sequence analysis of the PCR
products from eight positive individuals and the dog
conﬁrm that the product was from B. pilosicoli, with
all having >98.8% sequence homology with the type
strain.
Risk factors for B. pilosicoli
In univariate analysis the factors found to be signiﬁ-
cant in relation to colonization with B. pilosicoli are
listed in Table 3. These included: other family mem-
bers being colonized with B. pilosicoli, estate, religion,
not visiting a doctor in the preceding 12 months, type
of worker, water source, water treatment, and cat
ownership. After logistic regression, remaining sig-
niﬁcant factors were: other family member being
colonized with B. pilosicoli (P<0.001), water sourced
from a well (P=0.006), drinking water treatment
(P=0.04), and not visiting a doctor (P=0.03)
(Table 4).
Table 1. Factors associated with colonization with
B. aalborgi having a P value <0.25 in x
2 analysis, and
consequently being included for examination in a
logistic regression model
Factor Prevalence (%) P value
Other family member
infected with B. aalborgi
66.7 <0.0001
No other family member
infected with B. aalborgi
4.8
Estate 0.19
Phulbari 6.9
Addabarie 3.3
Balipara 10.2
Religion 0.07
Hindu 5.3
Christian 5.4
Muslim 0
Buddhist 23.1
Staﬀ worker 11.80 .06
Tea picker 4.9
Treated drinking water 9.70 .007
Water not treated 2.5
Own an animal 6.50 .24
Don’t own an animal 0.0
Own a dog 7.80 .13
Don’t own a dog 3.7
Own a cat 13.60 .12
Don’t own a cat 5.5
Own a cow 7.60 .24
Don’t own a cow 4.5
Own a goat 7.80 .24
Don’t own a goat 4.6
Own a pig 0.00 .18
Don’t own a pig 6.6
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None of the three health-related factors analysed had
asigniﬁcantassociationwithB.pilosicolicolonization.
DISCUSSION
The use of PCR for detection of B. pilosicoli in faeces
identiﬁed a relatively high prevalence of colonization
amongst the individuals tested (25.3%). This preva-
lence was similar to prevalences found in previous
studies in developing communities, where selective
culture was used to detect the spirochaete. These in-
clude studies conducted in Oman (22.7%) [8], Papua
New Guinea (22.8%) [9], and in Aboriginals in a
community in the remote north of Western Australia
(32.6%) [10]. Immigrants to Western Australia from
a variety of developing countries have been shown
to have a colonization rate of 10.6% on arrival in
Australia [13]. The similarities between the preva-
lences in these studies helps to validate the accuracy
of PCR as used here for detection of B. pilosicoli
in faeces, and suggests that the dichromate treatment
of the samples did not have a deleterious eﬀect on
the sensitivity of the tests. Although the sensitivity
of direct faecal PCR, as assessed in seeded faeces, was
1–2 logs less than that reported for PCR applied to
primary growth of B. pilosicoli harvested from selec-
tive agar plates (i.e. >5r10
4 cells/g faeces), it is ap-
proximately equivalent to the sensitivity of detection
achieved by culture alone [33]. Clearly, it is probable
that there were other individuals who were colonized,
but who went undetected because they were only
shedding small numbers of spirochaetes in their faeces
at the time of sampling.
The overall prevalence of B. aalborgi in the study
population was 6%, signiﬁcantly less than the 25%
for B. pilosicoli (x
2=44.57; P<0.001). The relatively
lower prevalence recorded for B. aalborgi was not
likely to be a technical artifact, since when used on
seeded faeces the PCR was actually more sensitive
than was the PCR for B. pilosicoli (by 1 log). This
is the ﬁrst study to provide an estimate of the preva-
lence of B. aalborgi in the general population of a
developingcountry.Unfortunately,therehavebeenno
studies on the prevalence of B. aalborgi in developed
countries, apart from in selected groups of patients
who have undergone colorectal biopsy for underlying
complaints of the large bowel [21, 25–28]. In the
Table 2. Factors associated with the presence of B. aalborgi that remained in the ﬁnal logistic regression model
Factor b S.E.(b)
Association with infection
P value OR (95% CI)
Constant x4.08 0.57 —
Other family members infected
with B. aalborgi
3.45 0.93 31.4( 5 .0–196.4) <0.001
Resident of Balipara 1.28 0.59 3.6( 1 .13–11.4) 0.03
Treatment of water 1.32 0.61 3.8( 1 .14–12.4) 0.03
Table 3. Factors associated with colonization with
B. pilosicoli having a P value <0.25 in x
2 analysis,
and consequently being included for examination in a
logistic regression model
Factor
Prevalence
(%) P value
Other family member
infected with B. pilosicoli
62.1 <0.0001
No other family member
infected with B. pilosicoli
11.4
Estate <0.0001
Phulbari 36.6
Addabarie 18.9
Balipara 8.2
Religion 0.0001
Hindu 22.7
Christian 25.7
Muslim 100.0
Buddhist 46.2
Visited a doctor in
preceding 12 months
23 0.13
Hadn’t visited a doctor in
preceding 12 months
31.4
Staﬀ worker 35.30 .07
Tea picker 23.4
Drinking water from tap 22.90 .02
Water from well 39.1
Treated drinking water 27.90 .01
Water not treated 22.8
Own a cat 36.40 .22
Don’t own a cat
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to determine whether the prevalence of colonization
that was detected is unusually high or low, or whether
it was inﬂuenced by factors peculiar to developing
countries.
When considering factors that may increase the risk
of human colonization with intestinal spirochaetes,
the ﬁrst interesting feature of the current study was
the signiﬁcantly increased proportion of individuals
infected with both spirochaete species. This ﬁnding
suggests that the two species are likely to share at
least some risk factors for colonization. In logistic
regression, both spirochaete species showed a highly
signiﬁcant association with the existence of other
family members who were colonized with the same
species. This result suggests either that the whole
family had an increased exposure to a source of in-
fection, and/or that transmission of intestinal spiro-
chaetes within a household is an important means of
spread. Exposure to intestinal spirochaetes may be
either through direct contact with contaminated fae-
ces, or by indirect contact via contaminated fomites.
The people involved in the study lived in relatively
crowded conditions, lacking proper hygienic facilities,
and under these circumstances transmission is likely
to be enhanced. If these are the main means of trans-
mission for both spirochaete species, the diﬀerence
in prevalence for the two species in the study popu-
lation suggests that B. aalborgi is less infectious than
is B. pilosicoli. In the laboratory, B. aalborgi grows
much more slowly than B. pilosicoli – and the same
may be true in vivo. Successful intestinal colonization
may need exposure to a greater number of B. aalborgi
cells than is required for B. pilosicoli, and, equally,
B. aalborgi may be shed in lower numbers in the faeces
than is B. pilosicoli. Another possible explanation
for the diﬀerence in prevalence could be that the
organisms have diﬀerent environmental or animal
reservoirs, and that comparative exposure to these
reservoirs diﬀers amongst the humans examined. This
interpretation did not receive any clear support from
the results of the analysis of the questionaire; for
example, in logistic regression analysis, neither spiro-
chaete species was linked to animal ownership, even
though animals are known to be a potential reservoir
of B. pilosicoli.
The other signiﬁcant risk factor that applied to
both species was treatment of drinking water. As
treatment of water is not likely to predispose to in-
fection, it may be that the water sources available
to the individuals who treated their water were of
inferior quality to those of individuals who did not
treat their water. This then suggests a possible link
between water quality and infection with the spiro-
chaetes. Less than half of the people performed any
type of treatment on their household drinking water
before use. The most common method of treatment
was boiling, used by 39% of respondents. The re-
mainder used ﬁltration (3.5%), chemical treatment
(1.3%), or a combination of ﬁltration and boiling
(4.5%). For B. pilosicoli, obtaining drinking water
from a well was also a signiﬁcant risk factor that re-
mained in the ﬁnal logistic regression model. Again
this suggests that contaminated water supplies may
be a source of infection. Other studies have shown
that B. pilosicoli may be present in natural water
sources, particularly those contaminated with faeces
from water birds [15]. Further work is required to
determine whether B. aalborgi also can survive in
water, which would then represent a reservoir for
infection.
For B. aalborgi, being resident in Balipara was a
risk factor, and it would be useful to conduct future
studies at this estate, particularly examining water
sources for potential contamination. The other sig-
niﬁcant risk factor for B. pilosicoli infection was not
visiting a doctor in the last 12 months. All people
in the sample set had access to a doctor, provided
Table 4. Factors associated with the presence of B. pilosicoli that remained in the ﬁnal logistic regression model
Factor b S.E.(b)
Association with infection
P value OR (95% CI)
Constant x2.15 0.36 —
Other family members infected
with B. pilosicoli
2.76 0.33 15.8( 8 .3–30.0) <0.001
Water sourced from a well 1.13 0.41 3.1( 1 .4–6.9) 0.006
Treatment of water 0.66 0.32 1.9( 1 .03–3.6) 0.04
Hadn’t visited a doctor in the
preceding 12 months
0.73 0.34 2.1( 1 .1–4.0) 0.03
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having the ability to access a doctor in itself was
not biasing these results. A possible explanation for
the eﬀect is that the individuals who visited the doctor
may have received antimicrobial therapy in conjunc-
tion with these visits, and this may have removed any
colonizing B. pilosicoli strains.
Some initial associations with animal ownership
were found for B. aalborgi infection, but these did
not remain in the ﬁnal regression model. For B. pilo-
sicoli, an initial association with cat ownership was
found, but again this was discarded in the logistic
regression model. Several species of animal are known
to be infected with B. pilosicoli, but to date the only
group of animals known to be infected with B. aal-
borgi are non-human primates [34, 35]. None of the
101 dogs sampled were found to be colonized by
B. aalborgi, and only one was positive for B. pilosicoli.
A study in Papua New Guinea found the prevalence
of B. pilosicoli in village dogs to be 5.3% (4/76 dogs),
compared to 22.8% in humans [36]. The low preva-
lence in dogs in that study, as in the present study,
suggests that they are unlikely to be a signiﬁcant
reservoir of B. pilosicoli infection for humans in
developing communities. Indeed, in such settings, it is
likely that dogs become colonized with B. pilosicoli
following consumption of contaminated human
faeces [9, 36].
For both spirochaete species, no signiﬁcant associ-
ations were found with the three indices of disease
that were recorded. In part this reﬂects the relatively
low frequency of reported symptoms, and the high
likelihood that these could have other causes in a
tropical setting. The survey did not elicit information
about chronic diarrhoea, and no attempt was made
to assess the individual water content of the faecal
samples obtained. Most faecal samples appeared
loose compared to faeces collected from individuals in
developed countries. It was unfortunate that water
content was not recorded, since IS has been linked
to chronic diarrhoea in humans [5, 6, 37, 38], whilst
B. pilosicoli infection in animals increases faecal
water content directly, and exacerbates diarrhoea due
to nutritional and other infectious causes [39, 40].
Colorectal biopsies were not taken in this study, so
it is not known whether any of the colonized indi-
viduals had colitis or histological evidence of IS.
Further work is needed to clarify whether infection
with one or other of the two spirochaete species has
an impact on health in individuals living in developing
communities.
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